Skip to content

HELIX DIAGNOSTICS

Pharmacogenomics (PGx) Fluoropyrimidines DPYD Test

Test Description

Coming Soon in June 2025

This test evaluates 1 gene associated with response to certain medications including fluoropyrimidines. Results from this test may help in predicting treatment efficacy and risk of side effects for these drugs.

Genes Tested (1)

DPYD

Important Test Information

Turnaround time: 7-10 days

Preferred specimen: BD Vacutainer Whole Blood K2 EDTA Collection Tube 4mL or Oragene Dx Saliva Collection Kit

Shipping Instructions: Specimens to arrive at Helix within 96 hours of collection at ambient temperature.

Cancer and other conditions

All detected variants are evaluated according to the Clinical Pharmacogenetics Implementation Consortium (CPIC). Variants are classified based on known, predicted, or possible impact on drug metabolism.

Other Tests to Consider

Malignant Hyperthermia Susceptibility Panel

3 genes

Pharmacogenomics (PGx) APOE Panel

Pharmacogenomics (PGx) Pain Panel

6 genes

Comprehensive Pharmacogenomics (PGx) Panel

26 genes